Parenteral Drug Association - New England Chapter Dinner Meeting and Facility Tour - Maintaining Supply Chain Security

Several recent incidences of intentional raw material adulteration have been widely publicized. These events have negatively impacted both pharmaceutical companies and their patients. Here is a great opportunity to learn the latest trends in ensuring security of your raw material supply chain from our panel of experts. The meeting will begin with a presentation “Analytical Technique selection for Detection of Raw Material Adulteration” describing one important element of Amgen’s strategy for eliminating the possibility of raw material adulteration. A panel discussion on best practices in supply chain security will follow the presentation.

Steve Niedelman is one of the panel participants.